Patel Chem Specialities IPO Subscription Status
Patel Chem Specialities IPO received bids for 78,01,66,400 shares against 50,12,800 offered, an overall subscription of 155.63x at the close of bidding (29 Jul 2025). NII leads at 175.00x.
Last updated · day 3 figures
- Retail
- 173.13x
- NII
- 175.00x
- QIB
- 105.27x
- Total
- 155.63x
Where the demand is
Patel Chem Specialities IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| QIB | 13,29,600 | 13,99,71,200 | ₹1,175.76 Cr | 105.27x |
| NII | 13,52,000 | 23,65,98,400 | ₹1,987.43 Cr | 175.00x |
| Retail | 23,31,200 | 40,35,96,800 | ₹3,390.21 Cr | 173.13x |
| Total | 50,12,800 | 78,01,66,400 | ₹6,553.40 Cr | 155.63x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Application-wise breakup and allotment chances
| Category | Lots reserved | Applications | Applied | Chance per application |
|---|---|---|---|---|
| QIB | — | 89 | — | — |
| NII | — | 25,400 | — | — |
| Retail | — | 1,26,124 | — | — |
"All valid" means applications are fewer than the lots reserved, so every valid application should get at least one lot. When applications exceed lots, allottees are picked by computerised lottery and "1 in X" is the rough chance for one application. The real chance is usually a little better: bids below the cut-off price and invalid applications are removed before the lottery.
Patel Chem Specialities IPO subscription day-wise
| Category | Day 3 |
|---|---|
| QIB | 105.27x |
| NII | 175.00x |
| Retail | 173.13x |
| Total | 155.63x |
| Total added | 155.63x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Patel Chem Specialities IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Qualified Institutional Buyers | 13,29,600 | 26.52% |
| Non-Institutional Investors | 13,52,000 | 26.97% |
| Retail Individual Investors | 23,31,200 | 46.50% |
| Public issue | 50,12,800 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Patel Chem Specialities IPO subscription: FAQs
- What is the overall subscription of Patel Chem Specialities IPO?
- Patel Chem Specialities IPO is subscribed 155.63x overall as of day 3 (29 July 2025), with bids for 78,01,66,400 shares against 50,12,800 offered.
- What is the retail subscription of Patel Chem Specialities IPO?
- The retail portion is subscribed 173.13x as of day 3 (29 July 2025).
- What is the QIB and NII subscription of Patel Chem Specialities IPO?
- QIBs have subscribed 105.27x of their portion, and NIIs 175.00x as of day 3 (29 July 2025).
- How can I check Patel Chem Specialities IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Patel Chem Specialities IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 29 July 2025.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.